ArticleFrontiers in immunology2026
Integrated single-cell and bulk tissue analyses reveal distinct macrophage subtypes and a candidate prognostic signature in colorectal cancer: implications for tumor immune characterization.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Colorectal cancer (CRC) represents a major global health burden, marked by high morbidity and mortality rates that place a considerable strain on healthcare systems. Methods: This study leveraged integrated bioinformatic analyses, single-cell RNA sequencing, and clinical sample validation to investigate the role of macrophage-related genes (MRGs) in CRC, with the goal of deepening our understanding of the complex interplay within the tumor microenvironment. Results: Differential expression analysis comparing CRC tumor and normal tissues in the TCGA-COADREAD cohort identified 1,962 differentially expressed genes (DEGs). In parallel, a predefined set of 1,719 MRGs was curated from public databases and the literature to define the macrophage-related biological context. By integrating the bulk transcriptomic DEGs, single-cell macrophage subtype-specific genes, and the predefined MRG set, we identified eight hub macrophage-related DEGs (MRDEGs) implicated in CRC. Functional enrichment analysis of these eight MRDEGs revealed significant roles in immune-regulatory processes, including leukocyte chemotaxis, eosinophil chemotaxis, chemokine receptor binding, and the chemokine signaling pathway. From these eight hub MRDEGs, we selected Discussion: This study provides a candidate prognostic stratification model that requires further validation in independent cohorts and prospective studies, offering a macrophage-related prognostic clue for future investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.